The non-benzodiazepine anxiolytic etifoxine limits mechanical allodynia and anxiety-like symptoms in a mouse model of streptozotocin-induced diabetic neuropathy.

More than 450 million people worldwide suffer from diabetes, or 1 in 11 people. Chronic hyperglycemia degrades patients' quality of life and the development of neuropathic pain contributes to the burden of this disease. In this study, we used the mouse model of streptozocin-induced diabetic typ...

Full description

Saved in:
Bibliographic Details
Main Authors: Géraldine Gazzo, Marlene Salgado Ferrer, Pierrick Poisbeau
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/b600b610af8d4133a6f1ddeb47c164d9
Tags: Add Tag
No Tags, Be the first to tag this record!